Dosing of factor VIII concentrate by ideal body weight is more accurate in overweight and obese haemophilia A patients

AIMS: Under‐ and, especially, overdosing of replacement therapy in haemophilia A patients may be prevented by application of other morphometric variables than body weight (BW) to dose factor VIII (FVIII) concentrates. Therefore, we aimed to investigate which morphometric variables best describe inte...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Br J Clin Pharmacol
Hlavní autoři: van Moort, Iris, Preijers, Tim, Hazendonk, Hendrika C.A.M., Schutgens, Roger E.G., Laros‐van Gorkom, Britta A.P., Nieuwenhuizen, Laurens, van der Meer, Felix J.M., Fijnvandraat, Karin, Leebeek, Frank W.G., Meijer, Karina, Mathôt, Ron A.A., Cnossen, Marjon H.
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley and Sons Inc. 2020
Témata:
Original Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8246536/
https://ncbi.nlm.nih.gov/pubmed/33232535
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.14670
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky